Guidewire Software to Present at Investor Conferences in September

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Guidewire Software, Inc. (NYSE: GWRE), a provider of software products to Property/Casualty insurers, today announced that its Chief Financial Officer, Richard Hart, will present at the following investor conferences in September:

• The Citi 2016 Global Technology Conference to be held in New York, NY. The Guidewire presentation is scheduled for Thursday, September 8, 2016 at 2:45 p.m. ET (11:45 a.m. PT).
• The Deutsche Bank 2016 Technology Conference to be held in Las Vegas, NV. The Guidewire presentation is scheduled for Wednesday, September 14, 2016 at 1:20 p.m. PT (4:20 p.m. ET).

Live webcasts, as well as the replays, of both presentations will be available under the "Webcasts and Presentations" section on the Company's investor relations website at http://ir.guidewire.com.

About Guidewire Software

Guidewire delivers the software that Property/Casualty insurers need to adapt and succeed in a time of rapid industry change. We combine three elements – core operations, data and analytics, and digital engagement – into a technology platform that enhances insurers’ ability to engage and empower their customers and employees. More than 200 insurers around the world have selected Guidewire. For more information, please visit www.guidewire.com. Follow us on twitter: @Guidewire_PandC.

NOTE: Guidewire, Guidewire Software, Guidewire ClaimCenter, Guidewire PolicyCenter, Guidewire BillingCenter, are registered trademarks of Guidewire Software, Inc. in the United States and/or other countries.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160901006482/en/

Investor Relations Contact:
ICR, LLC
Garo Toomajanian, +1 650-357-5282
[email protected]
or
Media Contact:
Guidewire Software, Inc.
Diana Stott, +1 650-356-4941
[email protected]

Source: Guidewire Software, Inc.

You May Also Be Interested In

• Rivian prices $1.16B stock offering at $15.50 per share
• SambaNova Completes First Close of $1 Billion Financing at $11 Billion Valuation
• WuXi Biologics Achieves MSCI ESG AAA Rating and MSCI Selection Indexes Inclusion for Fourth Consecutive Year